May 31, 2025 Kigali, Rwanda and San Francisco, USA

This past week, Bio Usawa’s CEO and Co- Founder, Dr. Menghis Bairu, received the prestigious 2025 African Diaspora Luminaire Award from The African Diaspora Network at its ADIS2025 meeting in Washington DC. In his remarks, Dr. Bairu expressed his gratitude and recognition of the transformational role that ADN continues to play in advancing investment in Africa and its communities – goals with which Bio Usawa is fully aligned. 

“I am deeply grateful for this honor, and wish to recognize the continued Leadership and Vision of the ADN in advocating for critical capital investment in Africa and strengthening the entrepreneurial ecosystem across the globe”. 

The African Diaspora Luminaire Awards recognize distinguished African Diasporans making high-level impact on a global scale. African Diaspora Network (ADN) annually celebrates luminaires who have made exceptional contributions and demonstrate a commitment to advance the African continent and the communities in which we live. Recipients of the award are individuals who have made a significant difference through leadership in their field, their commitment to ADN, and/or through their leadership and advancements.

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.